Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Summary:
Type:
Status:
Interventions:
Lumbrokinase
Locations:
New York, United States
Last Updated:
November 6, 2024
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Summary:
Type:
Status:
Interventions:
IV normal saline, IV immunoglobulin
Locations:
Bethesda, United States
Last Updated:
November 2, 2024
Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions
Summary:
Type:
Status:
Locations:
Palo Alto, United States; Rochester, United States; and 2 more
Last Updated:
November 1, 2024
RECOVER-ENERGIZE Platform Protocol
Summary:
Type:
Status:
Interventions:
Personalized Cardiopulmonary Rehabilitation, Structured Pacing, Education, Usual Care
Locations:
Birmingham, United States; Phoenix, United States; and 35 more
Last Updated:
November 1, 2024
Long COVID-19 [11C]CPPC Study
Summary:
Type:
Status:
Interventions:
[11C]CPPC Injection, [11C]CPPC Injection
Locations:
Baltimore, United States
Last Updated:
October 29, 2024
A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid
Summary:
Type:
Status:
Interventions:
Amantadine, Physical, Occupational, Speech Therapy, Provider Counseling, Medications for symptoms management
Locations:
Dallas, United States
Last Updated:
October 28, 2024
Brain-Training Treatment for Long COVID in Older Adults
Summary:
Type:
Status:
Interventions:
NeuroFlex (computerized gamified tasks)
Locations:
Farmington, United States
Last Updated:
October 28, 2024
TVNS in Long COVID-19
Summary:
Type:
Status:
Interventions:
Transcutaneous vagus nerve stimulator
Locations:
New York, United States
Last Updated:
October 28, 2024
Procedural Motor Memory in Long COVID-19
Summary:
Type:
Status:
Interventions:
keypresses
Locations:
Bethesda, United States
Last Updated:
October 22, 2024
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Summary:
Type:
Status:
Interventions:
Baricitinib, Placebo
Locations:
Nashville, United States
Last Updated:
October 21, 2024